278 related articles for article (PubMed ID: 28923134)
1. β-1,3-Galactosyl-
Sumardika IW; Youyi C; Kondo E; Inoue Y; Ruma IMW; Murata H; Kinoshita R; Yamamoto KI; Tomida S; Shien K; Sato H; Yamauchi A; Futami J; Putranto EW; Hibino T; Toyooka S; Nishibori M; Sakaguchi M
Oncol Res; 2018 Apr; 26(3):431-444. PubMed ID: 28923134
[TBL] [Abstract][Full Text] [Related]
2. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
3. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
[TBL] [Abstract][Full Text] [Related]
4. exMCAM-Fc, an S100A8/A9-mediated-metastasis blocker, efficiently reduced the number of circulating tumor cells that appeared in the blood flow.
Tomonobu N; Kinoshita R; Sakaguchi M
Mol Biol Rep; 2020 Jun; 47(6):4879-4883. PubMed ID: 32383137
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness.
Chen Y; Sumardika IW; Tomonobu N; Kinoshita R; Inoue Y; Iioka H; Mitsui Y; Saito K; Ruma IMW; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Futami J; Kubo M; Putranto EW; Murakami T; Liu M; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
Neoplasia; 2019 Jul; 21(7):627-640. PubMed ID: 31100639
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
Wagner NB; Weide B; Gries M; Reith M; Tarnanidis K; Schuermans V; Kemper C; Kehrel C; Funder A; Lichtenberger R; Sucker A; Herpel E; Holland-Letz T; Schadendorf D; Garbe C; Umansky V; Utikal J; Gebhardt C
J Immunother Cancer; 2019 Dec; 7(1):343. PubMed ID: 31806053
[TBL] [Abstract][Full Text] [Related]
7. Neuroplastin-β mediates S100A8/A9-induced lung cancer disseminative progression.
Sumardika IW; Chen Y; Tomonobu N; Kinoshita R; Ruma IMW; Sato H; Kondo E; Inoue Y; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Futami J; Putranto EW; Hibino T; Nishibori M; Toyooka S; Sakaguchi M
Mol Carcinog; 2019 Jun; 58(6):980-995. PubMed ID: 30720226
[TBL] [Abstract][Full Text] [Related]
8. S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells.
Silva EJ; Argyris PP; Zou X; Ross KF; Herzberg MC
Int J Biochem Cell Biol; 2014 Oct; 55():279-87. PubMed ID: 25236491
[TBL] [Abstract][Full Text] [Related]
9. Histidine-Rich Glycoprotein Suppresses the S100A8/A9-Mediated Organotropic Metastasis of Melanoma Cells.
Tomonobu N; Kinoshita R; Wake H; Inoue Y; Ruma IMW; Suzawa K; Gohara Y; Komalasari NLGY; Jiang F; Murata H; Yamamoto KI; Sumardika IW; Chen Y; Futami J; Yamauchi A; Kuribayashi F; Kondo E; Toyooka S; Nishibori M; Sakaguchi M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142212
[TBL] [Abstract][Full Text] [Related]
10. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
[TBL] [Abstract][Full Text] [Related]
11. exSSSRs (extracellular S100 soil sensor receptors)-Fc fusion proteins work as prominent decoys to S100A8/A9-induced lung tropic cancer metastasis.
Kinoshita R; Sato H; Yamauchi A; Takahashi Y; Inoue Y; Sumardika IW; Chen Y; Tomonobu N; Araki K; Shien K; Tomida S; Torigoe H; Namba K; Kurihara E; Ogoshi Y; Murata H; Yamamoto KI; Futami J; Putranto EW; Ruma IMW; Yamamoto H; Soh J; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
Int J Cancer; 2019 Jun; 144(12):3138-3145. PubMed ID: 30365872
[TBL] [Abstract][Full Text] [Related]
12. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.
Khammanivong A; Sorenson BS; Ross KF; Dickerson EB; Hasina R; Lingen MW; Herzberg MC
Oncotarget; 2016 Mar; 7(12):14029-47. PubMed ID: 26883112
[TBL] [Abstract][Full Text] [Related]
13. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
14. S100A8/A9 in Inflammation.
Wang S; Song R; Wang Z; Jing Z; Wang S; Ma J
Front Immunol; 2018; 9():1298. PubMed ID: 29942307
[TBL] [Abstract][Full Text] [Related]
15. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis.
Ghavami S; Chitayat S; Hashemi M; Eshraghi M; Chazin WJ; Halayko AJ; Kerkhoff C
Eur J Pharmacol; 2009 Dec; 625(1-3):73-83. PubMed ID: 19835859
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.
Grebhardt S; Veltkamp C; Ströbel P; Mayer D
Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
[TBL] [Abstract][Full Text] [Related]
18. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.
Khammanivong A; Wang C; Sorenson BS; Ross KF; Herzberg MC
PLoS One; 2013; 8(7):e69395. PubMed ID: 23874958
[TBL] [Abstract][Full Text] [Related]
19. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
[TBL] [Abstract][Full Text] [Related]
20. S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells.
Qin F; Song Y; Li Z; Zhao L; Zhang Y; Geng L
Pathol Oncol Res; 2010 Sep; 16(3):353-60. PubMed ID: 19957061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
